BU-NOT-SET

CONTACT US
Manufacturing Chemist CDMO roundtable – part one
  • Industry trends
Eyes
Insight
Increased drive to outsource manufacturing in life science
  • Industry trends
  • Manufacturing
Eyes
Insight
Serialisation: the final countdown
  • Manufacturing
Eyes
Insight
For lyophilisation, excipients really do matter
  • Drug product
Eyes
Insight
The challenges of serialisation
  • Manufacturing
Eyes
Insight
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
  • Drug substance
Eyes
Insight
Strategies to prepare for serialisation
  • Manufacturing
Eyes
Insight
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones
  • Drug substance
Eyes
Insight
Case study
  • Drug product
  • Manufacturing
Science-led OSD reformulation
Case study
  • Development
  • Drug product
De-risking complex generic OSD development
Insight
  • Development
  • Drug product
Science-led OSD development
White paper
  • Drug product
  • Manufacturing
Advanced deformulation for complex generic development
Webinar
  • Development
  • Drug product
How to turn development challenges into predictable outcomes
Insight
  • Drug product
Managing risk as high-potency manufacturing scales
Insight
  • Drug product
Safely scaling high potency API manufacturing
eBook
  • Development
  • Drug product
A predictive approach to complex OSD development
Video
  • Development
Predictable development for uneventful manufacturing